⌘K
Loading ticker…
Harmony Biosciences Holdings, Inc. Common Stock · Healthcare · Pharmaceutical Products
As of 2026-06-26, Harmony Biosciences Holdings, Inc. Common Stock (HRMY) has a 3-month relative strength percentile of 80 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 55. The current market Stance is 47 (Neutral). Sector: Healthcare. Average daily range 3.3%, relative volume 2.16×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Diluted EPS, last 8 quarters. Positive EPS uses YoY change.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
3m RS is 80, Market Stance is mixed at 47, A/D rating B
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
Daily range, ATR, beta, and the math for a 1-ADR stop.
Strong relative strength, but attention is quiet relative to this name’s own recent norm. Academic work links low public attention to better forward returns on average — context to weigh, not a forecast.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
News
HRMY is held by 9 ETFs as of Mar 2026. Top owner: IJR at 0.07% weight, $67M notional. Top 3 carry $143M.
Top 9 by value, from SEC N-PORT-P filings dated Mar 2026.
| ETF | Weight | Value |
|---|---|---|
| IJRiShares Core S&P Small-Cap ETF | 0.07% | $67M |
| VTIVanguard Total Stock Market ETF | 0.00% | $44M |
| VBVanguard Small Cap ETF | 0.02% | $32M |
| IWMiShares Russell 2000 ETF | 0.04% | $30M |
| VBKVanguard Small-Cap Growth ETF | 0.05% | $18M |
| VXFVanguard Extended Market ETF | 0.02% | $13M |
| IWOiShares Russell 2000 Growth ETF | 0.08% | $10M |
| XPHState Street SPDR S&P Pharmaceuticals ETF | 1.87% | $6M |
| ITOTiShares Core S&P Total U.S. Stock Market ETF | 0.00% | $1M |
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | HRMY Jan avg: -1.17% median: -2.38% win: 25% σ: 10.40% n: 4 2022-04-12 → 2026-05-29 | HRMY Feb avg: -10.34% median: -10.64% win: 25% σ: 9.80% n: 4 2022-04-12 → 2026-05-29 | HRMY Mar avg: -6.26% median: -1.90% win: 25% σ: 13.41% n: 4 2022-04-12 → 2026-05-29 | HRMY Apr avg: -2.66% median: -4.47% win: 20% σ: 8.80% n: 5 2022-04-12 → 2026-05-29 | HRMY May avg: 3.46% median: 1.06% win: 60% σ: 8.94% n: 5 2022-04-12 → 2026-05-29 | HRMY Jun avg: 1.96% median: 2.19% win: 75% σ: 8.28% n: 4 2022-04-12 → 2026-05-29 (current) | HRMY Jul avg: 7.02% median: 7.67% win: 100% σ: 5.69% n: 4 2022-04-12 → 2026-05-29 | HRMY Aug avg: 0.04% median: 3.67% win: 75% σ: 9.12% n: 4 2022-04-12 → 2026-05-29 | HRMY Sep avg: -5.71% median: -4.37% win: 50% σ: 15.57% n: 4 2022-04-12 → 2026-05-29 | HRMY Oct avg: -6.69% median: -8.00% win: 50% σ: 20.96% n: 4 2022-04-12 → 2026-05-29 | HRMY Nov avg: 17.46% median: 19.20% win: 100% σ: 7.53% n: 4 2022-04-12 → 2026-05-29 | HRMY Dec avg: 2.15% median: 2.64% win: 50% σ: 8.24% n: 4 2022-04-12 → 2026-05-29 |